Diet and prevention of coronary heart disease: The potential role of phytochemicals

Cardiovascular Research

Volumn 47, Issue 3, 2000, Pages 419-425

  Visioli, Francesco ^a   Borsani, Luisa ^a   Galli, Claudio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Coronary disease; Epidemiology; Free radicals

Indexed keywords

FREE RADICAL; ISOFLAVONE; NATURAL PRODUCT; OLIVE OIL; PHENOL DERIVATIVE;

CACAO; CORONARY ARTERY DISEASE; DIET; DIETARY INTAKE; HUMAN; PRIORITY JOURNAL; REVIEW; SOYBEAN; TEA; WINE;

CACAO; CORONARY DISEASE; DIET; DIETARY SUPPLEMENTS; FOOD, FORTIFIED; HUMANS; INCIDENCE; PHENOLS; PHYTOSTEROLS; PLANT OILS; PLANTS, EDIBLE; SOYBEANS; TEA; WINE;

EID: 0034683043     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00053-5     Document Type: Review

References (106)

1. Keys A. Mediterranean diet and public health: personal reflections. Am J Clin Nutr. 61:1995;1321S-1323S.
2. Position of the American Dietetic Association: functional foods. J Am Diet Assoc. 9:1999;1278-1285.
3. Harborne J.B. Methods in plant biochemistry, I: plant phenolics. 1989;Academic Press, London.
4. Harborne J.B. The flavonoids: advances in research since 1986. 1993;Chapman and Hall, London.
5. Toguri T., Umemoto N., Ohtani T. Activation of anthocyanin synthesis by white light in eggplant hypocotyl tissues, and identification of an inducible P-450. Plant Mol Biol. 23:1993;933-946.
6. Soleas G.J., Diamandis E.P., Goldberg D.M. Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal. 11:1999;287-313.
7. Peters J.L., Castillo F.J., Health R.L. Alteration of extracellular enzymes in pinto leaves upon exposure to air pollutants, ozone and sulfur dioxide. Plant Physiol. 121:1999;159-164.
8. Howard B.V., Kritchevsky D. Phytochemicals and cardiovascular disease. Circulation. 95:1999;2591-2593.
9. Adlercreutz H., Mazur W. Phyto-oestrogens and western diseases. Ann Med. 29:1997;95-120.
10. Wilcox J.N., Blumenthal B.F. Thrombotic mechanisms in atherosclerosis: potential impact of soy proteins. J Nutr. 125:1995;631S-638S.
11. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol. 32:1983;1141-1148.
12. Anderson J.W., Johnstone B.J., Cook-Newell M.E. Meta-analysis of the effects of soy protein intake on serum lipids. New Engl J Med. 333:1995;276-282.
13. Anderson J.W., Smith B.M., Washnock C.S. Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr. 70:1999;464S-474S.
14. Akiyama M., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 262:1987;5592-5595.
15. Sirtori C.R., Lovati M.R., Manzoni C., Gianazza E., Bondioli A., Staels B., Auwerx J. Reduction of serum cholesterol by soy proteins: clinical experience and potential molecular mechanisms. Nutr Metab Cardiovasc Res. 8:1998;334-340.
16. Yusuf S Anand S. Cost of prevention. The case of lipid lowering. Circulation. 93:1996;1774-1776.
17. Balentine A.D. Manufacturing and chemistry of tea. Chi-Tang H., Chang Y.L., Mou-Tan H. Phenolic compounds in food and their effects on health I. 1992;103-117 ACS, Washington, DC.
18. Vinson J.A., Dabbagh Y.A. Tea phenols: antioxidant effectiveness of teas, tea components, tea fractions and their binding with lipoproteins. Nutr Res. 18:1998;1067-1075.
19. Lotito S.B., Fraga C.G. (+)-Catechin prevents human plasma oxidation. Free Radic Biol Med. 24:1998;435-441.
20. Kuroda Y., Hara Y. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res. 436:1999;69-97.
21. Cao Y., Cao R. Angiogenesis inhibited by drinking tea. Nature. 398:1999;381.
22. Hertog M.G.L., Hollman P.C.H., Katan M.B., Kromhout D. Estimation of daily intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer. 20:1993;21-29.
23. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen elderly study. Lancet. 342:1993;1007-1011.
24. Geleijnse J.M., Lauber L.J., Hofman A., Pols H.A.P., Witteman J.C.M. Tea flavonoids may protect against atherosclerosis. The Rotterdam Study. Arch Intern Med. 159:1999;2170-2174.
25. Hertog M.G., Kromhout D., Aravanis C., et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study [published erratum appears in Arch Intern Med 1995 Jun 12;155(11):1184]. Arch Intern Med. 155:1995;381-386.
26. Princen H.M., van Duyvenvoorde W., Buytenhek R., et al. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol. 18:1998;833-841.
27. Tijburg L.B., Wiseman S.A., Meijer G.W., Weststrate J.A. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis. 135:1997;37-47.
28. Ishikawa T., Suzukawa M., Ito T., et al. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr. 66:1997;261-266.
29. Crawford R.S., Kirk E.A., Rosenfeld M.E., LeBoeuf R.C., Chait A. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol. 18:1998;1506-1513.
30. Serafini M., Ghiselli A., Ferro-Luzzi A. In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr. 50:1996;28-32.
31. Maxwell S., Thorpe G. Tea flavonoids have little short term impact on serum antioxidant activity. Br Med J. 313:1996;229.
32. Cherubini A., Beal M.F., Frei B. Black tea increases the resistance of human plasma to lipid peroxidation in vitro, but not ex vivo. Free Radic Biol Med. 27:1999;381-387.
33. Da Silva E.L., Piskula M., Terao J. Enhancement of antioxidative ability of rat plasma by oral administration of (-)-epicatechin. Free Radic Biol Med. 24:1998;1209-1216.
34. van het Hof K.H., de Boer H.S.M., Wiseman S.A., Lien N., Westrate J.A., Tijburg L.B. Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr. 66:1997;1125-1132.
35. Hertog M.G.L., Sweetnam P.M., Fehily A.M., Elwood P.C., Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr. 65:1997;1689-1694.
36. Renaud S de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1992;1523-1526.
37. Fauconneau B., Waffo-Teguo P., Huguet F., Barrier L., Decendit A., Merillon J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci. 61:1997;2103-2110.
38. Duthie G.G., Pedersen M.W., Gardner P.T., Morrice P.C., Jenkinson A.M., McPhail D.B., Steele G.M. The effect of whisky and wine consumption on total phenol content and antioxidant capacity of plasma from healthy volunteers. Eur J Clin Nutr. 52:1998;733-736.
39. Furham B., Lavy A., Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low density lipoprotein to lipid peroxidation. Am J Clin Nutr. 61:1995;549-554.
40. Kondo K., Matsumoto A., Kurata H., Tanahashi H., Koda H., Amachi T., Itakura H. Inhibition of oxidation of low density lipoprotein with red wine. Lancet. 344:1994;1152.
41. Whitehead T.P., Robinson D., Allaway S., Syms J., Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem. 41:1995;32-35.
42. de Rijke Y.B., Demacker P.N.M., Assen N.A., Sloots L.M., Katan M.B., Stalenhoef A.F.H. Red wine consumption does not affect oxidability of low density lipoproteins in volunteers. Am J Clin Nutr. 63:1996;329-334.
43. de Rijke Y.B., Demacker P.N.M., Assen N.A., Sloots L.M., Katan M.B., Stalenhoef A.F.H. Red wine consumption and oxidation of low-density lipoproteins. Lancet. 345:1999;325-326.
44. Stein J.H., Keevil J.G., Wiebe D.A., Aeschlimann S., Folts J.D. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation. 100:1999;1050-1055.
45. Demrow H.S., Slane P.R., Folts J.D. Administration of wine and grape juices inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 91:1995;1182-1188.
46. Belguendouz L., Fremont L., Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol. 53:1997;1347-1355.
47. Chanvitayapongs S., Draczynska-Lusiak B., Sun A.Y. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport. 8:1997;1499-1502.
48. Miller N.J., Rice-Evans C.A. Antioxidant activity of resveratrol in red wine. Clin Chem. 41:1995;1789.
49. Gehm B.D., McAndrews J.M., Chien P.Y., Jameson J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA. 94:1997;14138-14143.
50. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
51. Chen C.K., Pace-Asciak C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol. 27:1996;363-366.
52. Bertelli A.A., Giovannini L., Bernini W., Migliori M., Fregoni M., Bavaresco G. Antiplatelet activity of cis-resveratrol. Drugs Exp Clin Res. 22:1996;61-63.
53. Bertelli A.A., Giovannini L., Giannessi D., Migliori M., Bernini W., Fregoni M., Bertelli A. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React. 17:1995;1-3.
54. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem. 273:1998;21875-21882.
55. Rotondo S., Rajtar G., Manarini S., Celardo A., Rotillo D., de Gaetano G., Evangelista V., Cerletti C. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol. 123:1998;1691-1699.
56. Wilson T., Knight T.J., Beitz D.C., Lewis D.S., Engen R.L. Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits. Life Sci. 59:1996;L15-L21.
57. Di Tommaso D., Calabrese R., Rotilio D. Identification and quantitation of hydroxytyrosol in Italian wines. J High Resolut Chromatogr. 21:1998;549-553.
58. Fielding R. Does diet or alcohol explain the French paradox? Lancet. 345:1995;527-528.
59. Gaziano J.M., Hennekens C.H., Godfried S.L., Sesso H.D., Glynn R.J., Breslow J.L., Buring J.E. Type of alcoholic beverage and risk of myocardial infarction. Am J Cardiol. 83:1999;57.
60. Klatsky A., Armstrong M.A., Friedman G.D. Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization. Am J Cardiol. 80:1997;416-420.
61. Rimm E.B., Klatsky A., Grobbee D., Stampfer M.J. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? Br Med J. 312:1996;731-736.
62. Walsh G.P. Does diet or alcohol explain the French paradox? Lancet. 345:1995;528.
63. Friedman G.D., Klatsky A. Is alcohol good for your health? New Engl J Med. 329:1993;1882-1883.
64. Gaziano J.M., Hennekens C.H. Royal Colleges' advice on alcohol consumption: maintaining existing limits seems justified on current evidence. Br Med J. 311:1995;3-4.
65. EC Council regulations. 1992 356/92.
66. Tubaro F., Micossi E., Ursini F. The antioxidant capacity of complex mixtures by kinetic analysis of crocin bleaching inhibition. J AOCS. 73:1996;173-176.
67. Gutfinger T. Phenols in olive oil. J AOCS. 68:1981;966-968.
68. Papadopoulos G., Boskou D. Antioxidant effect of natural phenols on olive oil. J AOCS. 68:1991;669-671.
69. Tsimidou M., Papadopoulos G., Boskou D. Phenolic compounds and stability of virgin olive oil - Part 1. Food Chem. 45:1992;141-144.
70. Blekas G., Tsimidou M., Boskou D. Contribution of α-tocopherol to olive oil stability. Food Chem. 52:1995;289-294.
71. Baldioli M., Servili M., Perretti G., Montedoro G. Antioxidant activity of tocopherols and phenolic compounds of virgin olive oil. J AOCS. 73:1996;1589-1593.
72. 2-isoprostanes in oxidized low density lipoprotein: inhibitory effect of hydroxytyrosol. Pharmacol Res. 31:1995;275-279.
73. Visioli F., Bellomo G., Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun. 247:1998;60-64.
74. Visioli F., Bellomo G., Montedoro G., Galli C. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis. 117:1995;25-32.
75. Visioli F., Galli C. Oleuropein protects low density lipoprotein from oxidation. Life Sci. 55:1994;1965-1971.
76. Aruoma O.I., Deiana M., Jenner A., Halliwell B., Harparkash K., Banni S., Corongiu F.F., Dessi' M.A., Aeschbach R. Effect of hydroxytyrosol found in extra virgin olive oil on oxidative DNA damage and on low-density lipoprotein oxidation. J Agric Food Chem. 46:1998;5181-5187.
77. Sajia A., Trombetta D., Tomaino A., Lo Cascio R., Princi P., Uccella N., Bonina F., Castelli F. In vitro evaluation of the antioxidant activity and biomembrane interaction of the plant phenols oleuropein and hydroxytyrosol. Int J Pharm. 166:1998;123-133.
78. Aeschbach R., Loliger J., Scott B.C., Murcia A., Butler J., Halliwell B., Aruoma O.I. Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem Toxicol. 32:1994;31-36.
79. Aruoma O.I. Nutrition and health aspects of free radicals and antioxidants [published erratum appears in Food Chem Toxicol 1994 Dec;32(12):1185]. Food Chem Toxicol. 32:1994;671-683.
80. Manna C., Galletti P., Cucciolla V., Moltedo O., Leone A., Zappia V. The protective effect of the olive oil polyphenol (3,4-dihydroxyphenyl)-ethanol counteracts reactive oxygen metabolite-induced cytotoxicity in Caco-2 cells. J Nutr. 127:1997;286-292.
81. Speroni E., Guerra M.C., Minghetti A., Crespi-Perellino N., Pasini P., Piazza F., Roda A. Oleuropein evaluated in vitro and in vivo as an antioxidant. Phytother Res. 12:1998;S98-S100.
82. Visioli F., Bellosta S., Galli C. Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages. Life Sci. 62:1998;541-546.
83. Visioli F., Galli C. The effect of minor constituents of olive oil on cardiovascular disease: new findings. Nutr Rev. 56:1998;142-147.
84. Galli C., Petroni A., Visioli F. Natural antioxidants, with special reference to those in olive oil, and cell protection. Eur J Pharm Sci. 2:1994;67-68.
85. Visioli F., Galli C. Natural antioxidants and prevention of coronary heart disease: the potential role of olive oil and its minor constituents. Nutr Metab Cardiovasc Dis. 5:1995;306-314.
86. Visioli F., Galli C. Olive oil polyphenols and their potential effects on human health. J Agric Food Chem. 46:1998;4292-4296.
87. Visioli F., Petroni A., Galli C. Phenolic compounds extracted from olive oil prevent oxidation of Low Density Lipoproteins, and inhibit platelet function and platelet and leukocyte eicosanoid production in vitro. Paoletti R., Samuelsson B., Catapano A.L., Poli A., Rinetti M. Oxidative processes and antioxidants. 1994;199-206 Raven Press, New York.
88. Petroni A., Blasevich M., Salami M., Servili M., Montedoro G.F., Galli C. A phenolic antioxidant extracted from olive oil inhibits platelet aggregation and arachidonic acid metabolism in vitro. World Rev Nutr Dietetics. 75:1994;169-172.
89. Bai C., Yan X., Takenaka M., Sekiya K., Nagata T. Determination of synthetic hydroxytyrosol in rat plasma by GC-MS. J Agric Food Chem. 46:1998;3998-4001.
90. Scaccini C., Nardini M., D'Aquino M., Gentili V., Di Felice M., Tomassi G. Effect of dietary oils on lipid peroxidation and on antioxidant parameters of rat plasma and lipoprotein fractions. J Lipid Res. 33:1992;627-633.
91. Wiseman S.A., Mathot J.N., de Fouw N.J., Tijburg L.B. Dietary non-tocopherol antioxidants present in extra virgin olive oil increase the resistance of low density lipoproteins to oxidation in rabbits. Atherosclerosis. 120:1996;15-23.
92. Visioli F., Vinceri F.F., Galli C. 'Waste waters' from olive oil production are rich in natural antioxidants. Experientia. 51:1995;32-34.
93. Visioli F., Romani A., Zarini S., Conte D., Vinceri F.F., Galli C. Antioxidant and other biological activities of olive mill waste waters. J Agric Food Chem. 47:1999;3397-3401.
94. Waterhouse A.L., Shirley J.R., Donovan J.L. Antioxidants in chocolate. Lancet. 348:1996;834.
95. Zeigleder G., Sandmeier D. Antioxidative effects of cocoa. Rev Choc Confect Bak. 8:1983;3-6.
96. Kondo K., Hirano R., Matsumoto A., Igarashi O., Itakura H. Inhibition of LDL oxidation by cocoa. Lancet. 348:1996;1514.
97. Osakabe N., Sanbongi C., Yamagishi M., Takizawa T., Osawa T. Effects of polyphenol substances derived from Theobroma cacao on gastric mucosal lesion induced by ethanol. Biosci Biotech Biochem. 62:1998;1535-1538.
98. Osakabe N., Yamagishi M., Sanbongi C., Natsume M., Takizawa T., Osawa T. The antioxidative substances in cacao liquor. J Nutr Sci Vitamin. 44:1998;313-321.
99. Sanbongi C., Suzuki N., Sakane T. Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro. Cell Immunol. 177:1997;129-136.
100. Arts I.C.W., Hollman P.C.H., Kromhout D. Chocolate as a source of tea flavonoids. Lancet. 354:1999;488.
101. Singh R.B., Rastogi S.S., Verma R., Laxmi B., Singh R., Ghosh S., Niaz M.A. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow-up. Br Med J. 304:1992;1015-1019.
102. Miller E.R., Appel L.J., Risby T.H. Effect of dietary patterns on measures of lipid peroxidation: results from a randomized clinical trial. Circulation. 98:1998;2390-2395.
103. Visioli F. Antioxidants in the Mediterranean diet. Simopoulos A., Visioli F. Characteristics of the Mediterranean diets, World Rev Nutr Dietetics. vol. 87:2000;Karger Press, Basel.
104. Katan M. Flavonoids and heart disease. Am J Clin Nutr. 65:1997;1542-1543.
105. Diaz M.N., Frei B., Vita J.A., Keaney J.F. Antioxidants and atherosclerotic heart disease. New Eng J Med. 337:1997;408-416.
106. Marchioli R. Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Pharmacol Res. 40:1999;227-238.